Dalfó E - Search Results

1

Current advances on different kinases involved in tau phosphorylation, and implications in Alzheimer's disease and tauopathies.

Ferrer I, Gomez-Isla T, Puig B, Freixes M, Ribé E, Dalfó E, Avila J. Ferrer I, et al. Among authors: dalfo e. Curr Alzheimer Res. 2005 Jan;2(1):3-18. doi: 10.2174/1567205052772713. Curr Alzheimer Res. 2005. PMID: 15977985 Review.

2

Expression of stress-activated kinases c-Jun N-terminal kinase (SAPK/JNK-P) and p38 kinase (p38-P), and tau hyperphosphorylation in neurites surrounding betaA plaques in APP Tg2576 mice.

Puig B, Gómez-Isla T, Ribé E, Cuadrado M, Torrejón-Escribano B, Dalfó E, Ferrer I. Puig B, et al. Among authors: dalfo e. Neuropathol Appl Neurobiol. 2004 Oct;30(5):491-502. doi: 10.1111/j.1365-2990.2004.00569.x. Neuropathol Appl Neurobiol. 2004. PMID: 15488025

3

Phosphorylation of tau and alpha-synuclein in synaptic-enriched fractions of the frontal cortex in Alzheimer's disease, and in Parkinson's disease and related alpha-synucleinopathies.

Muntané G, Dalfó E, Martinez A, Ferrer I. Muntané G, et al. Among authors: dalfo e. Neuroscience. 2008 Apr 9;152(4):913-23. doi: 10.1016/j.neuroscience.2008.01.030. Epub 2008 Feb 5. Neuroscience. 2008. PMID: 18343584

4

Early modifications in the expression of mitogen-activated protein kinase (MAPK/ERK), stress-activated kinases SAPK/JNK and p38, and their phosphorylated substrates following focal cerebral ischemia.

Ferrer I, Friguls B, Dalfó E, Planas AM. Ferrer I, et al. Among authors: dalfo e. Acta Neuropathol. 2003 May;105(5):425-37. doi: 10.1007/s00401-002-0661-2. Epub 2003 Jan 21. Acta Neuropathol. 2003. PMID: 12677442

5

Metabotropic glutamate receptor/phospholipase C pathway: a vulnerable target to Creutzfeldt-Jakob disease in the cerebral cortex.

Rodríguez A, Freixes M, Dalfó E, Martín M, Puig B, Ferrer I. Rodríguez A, et al. Among authors: dalfo e. Neuroscience. 2005;131(4):825-32. doi: 10.1016/j.neuroscience.2004.12.023. Neuroscience. 2005. PMID: 15749337

6

Alpha-synuclein binding to rab3a in multiple system atrophy.

Dalfó E, Ferrer I. Dalfó E, et al. Neurosci Lett. 2005 May 20-27;380(1-2):170-5. doi: 10.1016/j.neulet.2005.01.034. Epub 2005 Feb 3. Neurosci Lett. 2005. PMID: 15854772

7

Oxidation, glycoxidation, lipoxidation, nitration, and responses to oxidative stress in the cerebral cortex in Creutzfeldt-Jakob disease.

Freixes M, Rodríguez A, Dalfó E, Ferrer I. Freixes M, et al. Among authors: dalfo e. Neurobiol Aging. 2006 Dec;27(12):1807-15. doi: 10.1016/j.neurobiolaging.2005.10.006. Epub 2005 Nov 28. Neurobiol Aging. 2006. PMID: 16310893

8

Abnormal levels of prohibitin and ATP synthase in the substantia nigra and frontal cortex in Parkinson's disease.

Ferrer I, Perez E, Dalfó E, Barrachina M. Ferrer I, et al. Among authors: dalfo e. Neurosci Lett. 2007 Mar 30;415(3):205-9. doi: 10.1016/j.neulet.2007.01.026. Epub 2007 Jan 14. Neurosci Lett. 2007. PMID: 17284347

9

Neuropathology of sporadic Parkinson disease before the appearance of parkinsonism: preclinical Parkinson disease.

Ferrer I, Martinez A, Blanco R, Dalfó E, Carmona M. Ferrer I, et al. Among authors: dalfo e. J Neural Transm (Vienna). 2011 May;118(5):821-39. doi: 10.1007/s00702-010-0482-8. Epub 2010 Sep 23. J Neural Transm (Vienna). 2011. PMID: 20862500 Review.

10

Abnormal alpha-synuclein interactions with Rab proteins in alpha-synuclein A30P transgenic mice.

Dalfó E, Gómez-Isla T, Rosa JL, Nieto Bodelón M, Cuadrado Tejedor M, Barrachina M, Ambrosio S, Ferrer I. Dalfó E, et al. J Neuropathol Exp Neurol. 2004 Apr;63(4):302-13. doi: 10.1093/jnen/63.4.302. J Neuropathol Exp Neurol. 2004. PMID: 15099020

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42 results

Search Page

Filters